Immatics (IMTX) Current Deferred Revenue (2019 - 2026)
Immatics' Current Deferred Revenue came in at $11.12 million for Q2 2026, down 59.7% from $27.61 million a year earlier and down 28.2% from the prior quarter.
Powered by 
Analysis
Immatics (IMTX) Current Deferred Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025, Immatics' Current Deferred Revenue was $17.87 million, down 54.0% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $38.86 million in FY2024 (-64.2%), $108.61 million in FY2023 (+58.6%), $68.46 million in FY2022 (+14.8%) and $59.65 million in FY2021 (+12.1%).
- The Q2 2026 figure represents the lowest quarterly Current Deferred Revenue in data going back to Q4 2019.
- Year-over-year, Current Deferred Revenue has declined for seven consecutive quarters, with an average decline of 51.8% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q4 2023 (growth of 63.0%), and the weakest in Q1 2025 (a decline of 74.6%).
- Business Quant data shows IMTX's Current Deferred Revenue at $15.48 million (Q1 2026), $18.41 million (Q4 2025) and $29.88 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Immatics | 939.02 Mn | -1.09 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.93 Mn |
| Mar 31, 2026 | 15.15 Mn |
| Dec 31, 2025 | 18.58 Mn |
| Sep 30, 2025 | 29.99 Mn |
| Jun 30, 2025 | 28.60 Mn |
| Mar 31, 2025 | 27.38 Mn |
| Dec 31, 2024 | 37.37 Mn |
| Sep 30, 2024 | 76.99 Mn |
| Jun 30, 2024 | 102.29 Mn |
| Mar 31, 2024 | 104.19 Mn |
| Dec 31, 2023 | 111.13 Mn |
| Sep 30, 2023 | 65.54 Mn |
| Jun 30, 2023 | 73.90 Mn |
| Mar 31, 2023 | 70.63 Mn |
| Dec 31, 2022 | 69.25 Mn |
| Sep 30, 2022 | 78.78 Mn |
| Jun 30, 2022 | 81.90 Mn |
| Mar 31, 2022 | 68.58 Mn |
| Dec 31, 2021 | 57.08 Mn |
| Sep 30, 2021 | 71.79 Mn |
API Access
Immatics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IMTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "IMTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IMTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();